13-02-2025 /

Interview with radiologist Dr. Martin Wasser

Dr. Martin Wasser on revolutionizing breast cancer detection with nu:view Breast CT
Detecting breast cancer early comes with significant challenges: How can we improve patient comfort without compromising diagnostic accuracy, especially for women with dense breast tissue?
In a compelling interview with Guido Gebhardt of DIEurope, Dr. Martin Wasser, a renowned radiologist at Leiden University Medical Center (LUMC) in the Netherlands, explores how groundbreaking technologies like breast CT could redefine breast cancer diagnostics—offering enhanced precision and a more comfortable experience for patients.

Dr. Wasser:
🗣️ “Breast CT combines the strengths of mammography, tomosynthesis, and MRI. It offers a 3D image similar to that of MRI, delivers high-resolution images that clearly show the tumor’s morphology, and can depict calcifications, which are important indications for DCIS”.
🗣️ “One significant benefit is its appeal to women who previously avoided screening due to discomfort from compression in mammography. Since breast CT does not require compression, many women who previously declined screening are now participating, making it possible to detect cancers that may have otherwise gone undiagnosed”.

Ongoing research at LUMC and other centers continues to validate breast CT’s role, with promising advancements such as integrated biopsy capabilities. These developments pave the way for breast CT to become an indispensable tool in personalized breast cancer care—enhancing both precision and patient comfort.

Read the whole interview here.